GTx (United States)
GTx, Inc. was a pharmaceutical company working on drugs in the selective estrogen receptor modulator and selective androgen receptor modulator classes. Its drugs in development included enobosarm and GTx-758. The company was founded in Memphis in 1997 by Mitch Steiner and Marc S. Hanover. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GTx (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
29%
Total
Publications
26K
Total Open
Publications
7.5K
Total
Citations
987K
Open Access
Percentage
29%
Total
Publications
26K
Total Open
Publications
7.5K
Total
Citations
987K
Breakdown
Publisher Open
12%
Both
7%
Other Platform Open
10%
Closed
71%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 8%
389
Hybrid 22%
1.1K
No Guarantees 70%
3.5K
Other Platform Open
Domain 73%
3.1K
Institution 30%
1.3K
Other Internet 7%
298
Public 4%
167
Preprint 4%
162
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 3.1K |
Europe PMC | Domain | 2.2K |
Semantic Scholar | Public | 131 |
Research Square | Preprint | 103 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 96 |
California Digital Library - eScholarship | Other Internet | 91 |
University of California - eScholarship University of California | Institution | 86 |
University College London - UCL Discovery | Institution | 78 |
University of Zurich - Zurich Open Repository and Archive | Institution | 57 |
RePEc: Research Papers in Economics - RePEc | Preprint | 57 |